{"id":1605,"date":"2024-08-30T19:18:20","date_gmt":"2024-08-30T19:18:20","guid":{"rendered":"https:\/\/daily-bullet.com\/?p=1605"},"modified":"2024-08-30T19:18:21","modified_gmt":"2024-08-30T19:18:21","slug":"u-s-army-selects-saabs-at4-solution-for-individual-assault-munition-program","status":"publish","type":"post","link":"https:\/\/daily-bullet.com\/?p=1605","title":{"rendered":"U.S. Army Selects Saab\u2019s AT4 Solution for Individual Assault Munition Program"},"content":{"rendered":"
\n

The U.S. Army has awarded Saab an Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which allows the U.S. Army to place orders for up to $494M over five years for the XM919 Individual Assault Munition (IAM) program. Saab\u2019s solution is the AT4CS TW (Confined Space Tandem Warhead).<\/p>\n<\/p>\n

Order values will be established individually when an order is placed under the IDIQ contract.<\/p>\n

Saab\u2019s new addition to the battle-tested AT4 family combines the capability of multiple existing shoulder-launched munitions while reducing soldier load, training complexity and logistics burden.\u00a0<\/p>\n

\u201cAt Saab, we continually adapt and improve our products to meet customer needs and protect the warfighter. Our new IAM solution enhances capabilities, removes combat burdens and is uniquely created to meet the U.S. customer\u2019s needs,\u201d said Erik Smith, president and CEO of Saab in the U.S. \u201cSaab has leveraged a successful, combat-proven system to make it even more effective, ultimately ensuring our solution is the best fit for the end-user.\u201d\u00a0<\/p>\n

The AT4 is a battle-tested, successful anti-armor weapon with more than one million systems produced for 15 countries around the world. Lightweight, man-portable, and fully disposable, the AT4 has been the U.S. Army\u2019s squad weapon since 1985. Saab has delivered more than 700,000 AT4 systems to the United States. \u00a0<\/p>\n

Editor\u2019s note: As an addendum to this press release from Saab, I\u2019d like to remind readers of the XM919 program which I mentioned during last year\u2019s NDIA Future Forces Capability conference in Huntsville<\/a>. <\/em><\/p>\n

The XM919 IAM tactical munition is a disposable, lightweight, single shot, multi-target, and Fire from Enclosure (FFE) capable Shoulder Launched Munition (SLM)<\/span> envisioned for use at the Squad level. It replaces the M72 LAW, M136 and M136A1 AT-4 anti-tank weapons, and M141 Bunker Defeat Munition<\/span>.<\/em><\/p>\n

\n\t\t\t\t\t
\n\t\t\t\t\t\tThis entry was posted
\n\t\t\t\t\t\t\t\t\t\t\t\ton Friday, August 30th, 2024 at 19:00\t\t\t\t\t\tand is filed under Army<\/a>, Contracts<\/a>, Munitions<\/a>, Press Release<\/a>.
\n\t\t\t\t\t\tYou can follow any responses to this entry through the RSS 2.0<\/a> feed.<\/p>\n

\t\t\t\t\t\t\t\t\t\t\t\t\tBoth comments and pings are currently closed.<\/p>\n

\t\t\t\t\t<\/small>\n\t\t\t\t<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

The U.S. Army has awarded Saab an Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which allows the U.S. Army to place orders for up to $494M over five years for the XM919 Individual Assault Munition (IAM) program. Saab\u2019s solution is the AT4CS TW (Confined Space Tandem Warhead). Order values will be established individually when an order […]<\/p>\n","protected":false},"author":1,"featured_media":1606,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":{"0":"post-1605","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-army"},"_links":{"self":[{"href":"https:\/\/daily-bullet.com\/index.php?rest_route=\/wp\/v2\/posts\/1605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/daily-bullet.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/daily-bullet.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/daily-bullet.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/daily-bullet.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1605"}],"version-history":[{"count":1,"href":"https:\/\/daily-bullet.com\/index.php?rest_route=\/wp\/v2\/posts\/1605\/revisions"}],"predecessor-version":[{"id":1607,"href":"https:\/\/daily-bullet.com\/index.php?rest_route=\/wp\/v2\/posts\/1605\/revisions\/1607"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/daily-bullet.com\/index.php?rest_route=\/wp\/v2\/media\/1606"}],"wp:attachment":[{"href":"https:\/\/daily-bullet.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1605"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/daily-bullet.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1605"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/daily-bullet.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}